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background: Only a few multicenter trials have provided controversial data on the beneficial effects of atrioventricular (AV) and interventricular 
(VV) intervals optimization on clinical outcomes in patients with cardiac resynchronization therapy (CRT). The objective of this study is to investigate 
the impact of AV and VV intervals optimization on the long-term clinical response of CRT using the database of the CRT Utilization By Interventional 
Cardiologists (CUBIC) Study.
methods: A total of 995 patients were enrolled in the CUBIC study which was a Japanese multicenter registry, and 501 patients with sinus rhythm 
were included in this study. Patients were divided into 2 groups according to the presence or absence of AV and VV intervals optimization. The 
primary endpoint was a > 15% reduction in left ventricular end-systolic volume at 6 months. Secondary endpoint was combined all-cause mortality 
and heart failure-related hospitalization.
results: Among the 501 study patients, 330 patients underwent AV and VV intervals optimization at the time of discharge after CRT device 
implantation. There was no significant difference in a proportion of reverse remodeling at 6 months (60% vs. 55%, p= 0.30) between patients with 
and without device optimization. The event rate of the secondary endpoint in optimization group (42%) was not significantly different from that in 
non-optimization group (44%) over 5-year follow-up (log-rank test, p= 0.33).
conclusions: AV and VV intervals optimization did not show significant clinical benefits at long-term follow-up in CUBIC registry. These data cannot 
support AV and VV intervals optimization routinely in all patients receiving CRT.
